전체 8345
-
- IACC Committee Meeting - July 2010
-
- - Thomas Insel, M.D. (2010/11/18)
- - Category : Interagency Autism Coordinating Committee
- The Interagency Autism Coordinating Committee (IACC) is a Federal advisory committee that coordinates all efforts within the Department of Health and Human Services (HHS) concerning autism spectrum disorder (ASD). Through its inclusion of both Federal and public members, the IACC helps to ensure that a wide range of ideas and perspectives are represented and discussed in a public forum.
The IACC mission is to:
Provide advice to the Secretary of Health and Human Services regarding Federal activities related to autism spectrum disorder.
Facilitate the exchange of information on and coordination of ASD activities among the member agencies and organizations.
Increase public understanding of the member agencies activities, programs, policies, and research by providing a public forum for discussions related to ASD research and services.
IACC meetings are open to the public and include presentations and discussions on a variety of topics, including activities and projects of the IACC, recent advances in science and autism policy issues. A portion of each meeting is reserved for public comment.
The Interagency Austism Coordinating Committee
IACC Committee Meeting - July 2010
-
- iPS Cell-based Cardiovascular Disease Modeling and Regeneration
-
- - Sean Wu, MD, Ph.D, Massachusetts General Hospital (2010/11/18)
- - Category : Stem Cell
- The Stem Cell Interest Group was established to enhance communication and to foster collaboration among scientists from varying disciplines interested in stem cells. Topics of interest include fundamental stem cell biology, ontogeny, gerontology, and the therapeutic potential of stem cells. The SCIG serves as an open forum for discussion and dissemination of knowledge about all aspects of stem cell biology.
iPS Cell-based Cardiovascular Disease Modeling and Regeneration
-
- Grants.gov Quarterly Stakeholder Webcast - July 2010
-
- - Phil Clark, Program Manager; Mary Tutman, Program Advisor and Kevin Harp, IT Specialist (2010/11/18)
- - Category : Grants.gov
- Grants.gov is your source to FIND and APPLY for federal grants. The U.S. Department of Health and Human Services is proud to be the managing partner for Grants.gov, an initiative that is having an unparalleled impact on the grant community.
For more information, visit
www.Grants.gov
Grants.gov Quarterly Stakeholder Webcast - July 2010
-
- Induced Pluripotent Stem Cells for Disease Modeling
-
- - George Q. Daley, M.D., Ph.D., Childrens Hospital Boston (2010/11/18)
- - Category : Wednesday Afternoon Lectures
- Important research contributions from Dr. Daley？？？s lab include the creation of customized stem cells to treat genetic immune deficiency in a mouse model (together with Rudolf Jaenisch), the differentiation of germ cells from embryonic stem cells (cited as a ？？？Top Ten Breakthrough？？？ by Science magazine in 2003), and the generation of disease-specific pluripotent stem cells by direct reprogramming of human fibroblasts (cited in the ？？？Breakthrough of the Year？？？ issue of Science magazine in 2008).
For more information, visit
http://wals.od.nih.gov
Induced Pluripotent Stem Cells for Disease Modeling
-
- 11TH Annual Advances in Cancer Prevention Lecture: "Cancer Prevention Therapy: Accomplishments and Challenges" (NIH Only)
-
- - Andrea De Censi, M.D., Galliera Hospital, Genova, Italy (2010/11/18)
- - Category : NIH Only
- The Annual Advances in Cancer Prevention Lecture is part of the NCI Summer Curriculum in the Cancer Prevention Progran and is part of the Principles and Practice of Cancer Prevention and Control Course being held from July 12 - August 13, 2010. The lecture is so named as it is the keynote lecture of the entire course and aims to highlight a prominent researcher in the area of cancer prevention and control who is at the forefront of his or her field. This year the speaker will be Dr. Andrea De Censi of Genoa, Italy.
Dr. Andrea De Censi is the director of Medical Oncology at the Galliera Hospital in Genova, Italy. He also serves as a consultant to the Division of Cancer Prevention at the European Institute of Oncology in Milan, Italy, where he was the director of the division from 1998-2003. Dr. De Censi graduated from the University of Pavia medical school with first class honors, and later specialized in Medical Oncology at the University of Genova Postgraduate Medical School. He holds a certificate in medical oncology from the European Society of Medical Oncology.
Dr. De Censi devotes his main clinical activity to the treatment of patients with solid tumors, with special interest in breast, colorectal, genitourinary and gynecological cancers. His scientific activity is focused on the conception, design, execution, analysis and interpretation of phase II and phase III cancer chemoprevention clinical trials, with a concentration in breast, colorectal, lung, ovarian and urological cancers. Specifically, he works as a principal investigator or co-PI in several phase II and phase III chemoprevention clinical trials involving nearly 10,000 subjects at increased risk, several of which are supported by the NCI or other American Foundations. Dr. De Censi has authored over 120 publications in peer-reviewed journals, and is a reviewer for several journals including the Journal of Clinical Oncology, Journal of National Cancer Institute and Clinical Cancer Research. A recent survey from the Institute of Scientific Information showed that he had the highest citation index among all Italian doctors in the previous 5 years within the field of clinical trials in all medical disciplines.
11TH Annual Advances in Cancer Prevention Lecture: "Cancer Prevention Therapy: Accomplishments and Challenges" (NIH Only)
-
- Therapeutic Potential of Human Pluripotent Stem Cells
-
- - Kaufman, Dan S.
National Institutes of Health (U.S.). Center for Regenerative Medicine. (2010/11/18) - - Category : NCRM Interview Lectures
- - Kaufman, Dan S.
- NCRM (NIH Center for Regenerative Medicine) Lecture
Dr. Kaufman is an Associate Professor of Medicine in the Division of Hematology, Oncology at the University of Minnesota.
His research interests focus on hematopoietic and endothelial cell development from human and non-human primate embryonic stem (ES) cells. This research uses ES cells to understand the earliest stages of hematopoiesis.
Therapeutic Potential of Human Pluripotent Stem Cells
-
- Talking Science: Designing and Deliverying Successful Oral Presentations
-
- - Sharon L. Milgran, PhD, OITE Director (2010/11/18)
- - Category : Career Development/OITE
- Science isnt complete until the results have been shared with interested others, and talking about your results is one of the important ways of making them public. This presentation will address topics including the an anatomy of a science talk, creating successful slides, delivering your content convincingly, ensuring that your talk is well-received, and answering questions. The information will help you with presentations in lab meetings and perhaps talking about the findings when you return to school.
http://www.training.nih.gov
Talking Science: Designing and Deliverying Successful Oral Presentations
-
- Development of the Vertebrate Hematopoietic System
-
- - Dr. David Traver, University of California (2010/11/18)
- - Category : Stem Cell
- The Stem Cell Interest Group was established to enhance communication and to foster collaboration among scientists from varying disciplines interested in stem cells. Topics of interest include fundamental stem cell biology, ontogeny, gerontology, and the therapeutic potential of stem cells. The SCIG serves as an open forum for discussion and dissemination of knowledge about all aspects of stem cell biology
For more information, visit
http://biology.ucsd.edu/faculty/traver.html
http://sigs.nih.gov/scig/Pages/default.aspx
Development of the Vertebrate Hematopoietic System
-
- Applying the Substance Abuse Confidentiality Regulations to Health Information Exchange (HIE)
-
- - National Coordinator for Health Information Technology & Substance Abuse and Mental Health Services Administration (2010/11/18)
- - Category : Special
- Key stakeholders and constituents are being invited to a meeting on August 4, 2010 to discuss the FAQs with the Federal agencies that developed this Federal guidance. The federal confidentiality law and regulations (codified as 42 U.S.C. and 42 CFR Part 2 were enacted almost three decades ago. During that time, the technology of electronic health records (EHRS) has evolved significantly and questions have emerged about the application of Part 2 to EHRs and HIE Recently, a series of Frequently Asked Questions was disseminated to address these questions.
Applying the Substance Abuse Confidentiality Regulations to Health Information Exchange (HIE)
-
- Progress Report: Perspective on National Health Care Reform and Its Implications for Both Health Care Delivery and Clinical Research
-
- - Atul Grover, MD, PhD, Chief Advocacy Officer, Association of American Medical Colleges (2010/11/18)
- - Category : Clinical Center Grand Rounds
- CC Grand Rounds for Clinical Fellows
Progress Report: Perspective on National Health Care Reform and Its Implications for Both Health Care Delivery and Clinical Research
Progress Report: Perspective on National Health Care Reform and Its Implications for Both Health Care Delivery and Clinical Research
-
- Pluripotent Stem Cells ？？？
-
- - Mahendra Rao, MD, PhD, VP, Life Technologies (2010/11/18)
- - Category : NCRM Interview Lectures
- NCRM (NIH Center for Regenerative Medicine) Lecture
Dr. Rao is internationally known for his research involving human embryonic stem cells (hESCs). He has worked in the stem cell field for more than twenty years, and has published more than 250 papers on stem cell research. Dr. Rao served as the Chair of the CBER (FDA) advisory committee (CTGTAC) and continues to work with the FDA and other regulatory authorities on ESC related issues, most recently as the CIRM and ISSCR liaison to the ISCT.
Pluripotent Stem Cells ？？？
-
- Minority Organ Donation: The Power of an Educated Community
-
- - Dr. Clive O. Callender, Howard University College of Medicine (2010/11/18)
- - Category : Health Disparities
- The National Center on Minority Health and Health Disparities (NCMHD) invites you to the next NIH Health Disparities Seminar Series scheduled for August 5, 2010. The theme for this months seminar is Donor Awareness.
Increasing awareness about organ donation should be a major concern for every American, especially people from health disparity populations. Everyday 18 patients on the organ transplant waiting list die while waiting for transplants, according to statistics from the National Kidney Foundation. In 2008, only 28,000 of the more than 100,000 patients on the list received transplants. More than half of the people on the list are from multicultural populations, according to Donate Life America, a non-profit operated with funds from the United Network for Organ Sharing. But racial and ethnic minorities accounted for a small percentage of organ donors. Fortunately, the number of donors from health disparity populations has substantially increased during the last 20 years.
Our speaker, Dr. Clive O. Callender, LaSalle D. Leffall of Howard University College of Medicine, is largely responsible for the increased number of organ donors from health disparity populations. Dr. Callender helped develop the first minority directed dialysis and transplant center and histocompatibility and immunogenetic laboratory in this country. He has been involved in grassroots and mainstream media efforts to educate health disparity populations about minority donation. With more than $10 million in funding the NCMHD, NIDDK and Howard University, minority donations doubled since 1990 to 30 percent. The number of African American organ donors has quadrupled from 8 per million to 53 per million. At this seminar Dr. Callender will discuss his challenges and successes recruiting organ donors from health disparity populations
The presentation abstract is available at
http://www.ncmhd.nih.gov/hdss/hdss_Aug10.html
http://www.ncmhd.nih.gov
Minority Organ Donation: The Power of an Educated Community
-
- Is Work Making You Fat?
-
- - Megan Nechanicky (2010/11/18)
- - Category : Focus on You Wellness
- Focus on You Wellness Lecture Series
Nutrition Knowledge for the 9-5
For more information, visit
http://dats.ors.od.nih.gov/wellness/lecture.htm
Is Work Making You Fat?
-
- Update on Myofascial Pain Syndrome: Translating the Evidence to Improve Outcomes through Physical Medicine and Rehabilitation
-
- - Shah, Jay.
National Institutes of Health (U.S.). Womens Health Special Interest Group. (2010/11/18) - - Category : Womens Health
- - Shah, Jay.
- Womens Health Special Interest Group sponsored by the Intramural Program on Research on Womens Health, the Office of Research on Womens Health and the Office of Intramural Research, OD, NIH
Update on Myofascial Pain Syndrome: Translating the Evidence to Improve Outcomes through Physical Medicine and Rehabilitation
-
- The acupuncture trials from Germany ？？？ What do they tell us about efficacy, effectiveness, cost-effectiveness and safety?
-
- - Witt, Claudia.
National Center for Complementary and Alternative Medicine (U.S.) (2010/11/18) - - Category : NCCAM Lectures
- - Witt, Claudia.
- The Complementary and Integrative Medicine Consult Service lecture series sponsored by NCCAM provides NIH clinical center staff with the opportunity to learn more about how the integration of various complementary and alternative medicine treatments can affect approaches in the research and practice for medicine.
Dr. Witt is currently the Vice Director, Professor for Complementary Medicine, and Head of the Division for Complementary Medicine at the Institute of Social Medicine, Epidemiology, and Health Economics at Charite University Medical Center in Berlin, Germany.
Dr. Witt？？？s research specialization includes clinical and epidemiological studies in complementary medicine, including acupuncture and qi gong. She also has a research focus on health economics and safety evaluations.
The acupuncture trials from Germany ？？？ What do they tell us about efficacy, effectiveness, cost-effectiveness and safety?
-
- Clinical Proteomic Technologies for Cancer Initiative (CPTC): RFA-CA-10-016 Pre-Application Meeting
-
- - Henry Rodriguez (2010/11/18)
- - Category : Special
- NCI program and review staff members will make presentations to explain the goals and objectives for Proteome Characterization Centers (PCCs) in the Clinical Proteomic Technologies for Cancer initiative (CPTC), to discuss the application peer review process, and to answer questions from the attendees. An NCI Grants Management Specialist will be available to answer financial questions.
Clinical Proteomic Technologies for Cancer Initiative (CPTC): RFA-CA-10-016 Pre-Application Meeting
-
- MicroRNA Regulation of Embryonic and Induced Pluripotent Stem Cells
-
- - Blelloch, Robert.
National Institutes of Health (U.S.). Center for Regenerative Medicine. (2010/11/18) - - Category : NCRM Interview Lectures
- - Blelloch, Robert.
- NCRM (NIH Center for Regenerative Medicine) Interview Lecture
Stem cells have the amazing ability to self-renew and differentiate into a variety of adult tissues. Embryonic stem cells can produce an entire embryo while adult stem cells have a more limited development potential. We have found that adult stem cells can be efficiently reprogrammed into embryonic stem cells by somatic cell nuclear transfer. Understanding the mechanisms limiting the developmental potential of adult stem cells and identifying means of expanding their developmental potential is a major focus of the lab.
MicroRNA Regulation of Embryonic and Induced Pluripotent Stem Cells
-
- Ethical Challenges at the Intersection of Clinical Research and Clinical Practice
-
- - Grady, Christine.
National Institutes of Health (U.S.) (2010/11/18) - - Category : Clinical Center Grand Rounds
- - Grady, Christine.
- Grand Rounds for Clinical Fellows
Ethical Challenges at the Intersection of Clinical Research and Clinical Practice
-
- Melatonin and Breast Cancer
-
- - Dr. Stephen Hill, Tulane University School of Medicine (2010/11/18)
- - Category : OCCAM Monthly Lecture Series
- The NCIs Office of Cancer Complementary and Alternative Medicine (OCCAM) invites you to view its monthly lecture series.
With the goal of informing the National Cancer Institute (NCI) community about the variety of ongoing research in cancer and complementary and alternative medicine (CAM), NCIs Office of Cancer Complementary and Alternative Medicine (OCCAM) has created a monthly lecture series on cancer CAM. These hour long lectures, occurring from 10 a.m. - 11 a.m. on the second Wednesday of each month, will feature a fifty minute presentation on a cancer CAM topic and allow ten minutes for questions.
For more information, visit
http://www.cancer.gov/cam/news_lectures.html
Melatonin and Breast Cancer
-
- Large-Scale Systematic Approaches Toward Regenerative Medicine
-
- - Minoru S. H . Ko, MD, PhD, NIA (2010/11/18)
- - Category : NCRM Interview Lectures
- NCRM (NIH Center for Regenerative Medicine) Lecture
Large-Scale Systematic Approaches Toward Regenerative Medicine